Rachmat Mauludin
Overview
Explore the profile of Rachmat Mauludin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
195
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Harsas N, Bachtiar E, Amir L, Mauludin R, Sunarso S, Yosefa V, et al.
Eur J Dent
. 2025 Mar;
PMID: 40073987
Objective: Regenerative periodontal surgical approaches require scaffolds in a form that can fill narrow and irregular defects. Each scaffold must be specially designed to conform to the shape of the...
2.
Adliani N, Rizaldy D, Wibowo M, Mauludin R, Sukrasno -
Pak J Pharm Sci
. 2024 Nov;
37(5):1163-1168.
PMID: 39495857
Acne vulgaris is an inflammatory skin disease caused by several factors, including an imbalance of microorganisms compared to the normal microbial distribution in healthy tissue. The Lauraceae family which have...
3.
Agustin E, Insanu M, Mauludin R
Pharm Nanotechnol
. 2023 Jun;
PMID: 37264623
Background: Mahkota Dewa (Phaleria macrocarpa) seed has various phytochemical compounds and low pharmacological activities, including antioxidant and anti-inflammatory activities. Objective: This research aimed to study nanoemulsion preparations of Mahkota Dewa...
4.
Al-Hakim N, Fidrianny I, Anggadiredja K, Mauludin R
Pharm Nanotechnol
. 2022 Apr;
10(4):299-309.
PMID: 35466890
Background: Banana (Musa sp.) is a plant rich in phytochemical compounds, especially antioxidants, which are hypothesized to inhibit the activity of acetylcholinesterase, an enzyme associated with Alzheimer's Disease. Objective: This...
5.
Ainurofiq A, Mauludin R, Mudhakir D, Soewandhi S
Pharmaceutics
. 2018 Jul;
10(3).
PMID: 29986403
Low physical stability is the limitation of the widespread use of amorphous drugs. The co-amorphous drug system is a new and emerging method for preparing a stable amorphous form. Co-amorphous...
6.
Ainurofiq A, Mauludin R, Mudhakir D, Soewandhi S
Res Pharm Sci
. 2018 Apr;
13(2):93-102.
PMID: 29606963
This study describes the formation of multicomponent crystal (MCC) of desloratadine (DES). The objective of this study was to discover the new pharmaceutical MCC of DES using several coformers. The...
7.
Ainurofiq A, Mauludin R, Mudhakir D, Umeda D, Soewandhi S, Putra O, et al.
Eur J Pharm Sci
. 2017 Sep;
111:65-72.
PMID: 28958892
We report the first multicomponent crystal of desloratadine, an important anti-histamine drug, with a pharmaceutically acceptable coformer of benzoic acid. The single crystal structure analysis revealed that this novel multicomponent...
8.
Rachmawati H, Budiputra D, Mauludin R
Drug Dev Ind Pharm
. 2014 Feb;
41(4):560-6.
PMID: 24502271
The aim of this work is to develop a curcumin nanoemulsion for transdermal delivery. The incorporation of curcumin inside a nanoglobul should improve curcumin stability and permeability. A nanoemulsion was...
9.
Rachmawati H, Edityaningrum C, Mauludin R
AAPS PharmSciTech
. 2013 Aug;
14(4):1303-12.
PMID: 23990077
Curcumin (CUR) has various pharmacological effects, but its extensive first-pass metabolism and short elimination half-life limit its bioavailability. Therefore, transdermal application has become a potential alternative to delivery CUR. To...
10.
Shubar H, Lachenmaier S, Heimesaat M, Lohman U, Mauludin R, Mueller R, et al.
J Drug Target
. 2010 Apr;
19(2):114-24.
PMID: 20367080
Toxoplasmic encephalitis (TE) is the most common clinical manifestation of reactivated infection with Toxoplasma gondii in immunocompromised patients that is lethal if untreated. The combination of pyrimethamine plus sulfadiazine or...